Beijing Aosaikang Pharmaceutical Co., Ltd. (SHE: 002755)

Beijing Aosaikang Pharmaceutical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	1,034	1,047	772.71	1,166	1,369	1,187
Trading Asset Securities	917.81	713.83	839.08	522.39	100	100
Cash & Short-Term Investments	1,952	1,761	1,612	1,688	1,469	1,287
Cash Growth	30.85%	9.25%	-4.51%	14.90%	14.14%	15.44%
Accounts Receivable	267.32	181.24	323.03	581.86	968.27	1,052
Other Receivables	14.39	49.88	25.21	16.29	24.79	44.45
Receivables	281.71	231.12	348.23	598.15	993.06	1,097
Inventory	181.59	167.49	141.53	141.84	168.74	226.56
Other Current Assets	21.68	27	36.56	59.14	16.01	24.55
Total Current Assets	2,437	2,186	2,138	2,487	2,647	2,635
Property, Plant & Equipment	471.91	478.4	547.14	658.33	706.66	772.92
Long-Term Investments	117.8	118.21	107.57	105.18	77.36	54.12
Other Intangible Assets	151.7	98.34	95.77	97.69	84.91	87.23
Long-Term Deferred Tax Assets	23.41	25.73	25.85	28.69	26.9	42.17
Long-Term Deferred Charges	560.82	563.46	453.7	342.02	257.47	87.51
Other Long-Term Assets	48.4	53.26	46.22	5.75	7.89	13.24
Total Assets	3,811	3,524	3,414	3,725	3,808	3,692
Accounts Payable	38.6	38.29	39.08	65.72	95.29	275.39
Accrued Expenses	11.3	183.84	119.56	133.48	299.13	476.85
Short-Term Debt	70.03	114.02	45.03	-	20.01	-
Current Portion of Long-Term Debt	3.73	-	-	-	-	-
Current Portion of Leases	-	3.03	3.45	2.61	-	-
Current Income Taxes Payable	18.72	3.59	2.13	7.54	13.14	2.7
Current Unearned Revenue	44.09	15.88	11.68	15.26	31.18	-
Other Current Liabilities	465.98	72.9	102.81	177.11	231.23	323.79
Total Current Liabilities	652.45	431.55	323.74	401.71	689.99	1,079
Long-Term Leases	7.74	6.75	8.92	11.52	-	-
Long-Term Unearned Revenue	62.25	64.72	55.81	68.93	69.41	60.21
Long-Term Deferred Tax Liabilities	9.91	10.18	12.56	15.08	15.49	36.59
Total Liabilities	732.35	513.2	401.03	497.24	774.89	1,176
Common Stock	928.16	928.16	928.16	928.16	928.16	928.16
Additional Paid-In Capital	95.4	136.94	50.73	0.94	1.49	1.31
Retained Earnings	1,904	1,828	1,977	2,295	2,101	1,584
Comprensive Income & Other	8.96	6.58	7.25	-5.9	-3.7	0.31
Total Common Equity	2,936	2,900	2,963	3,219	3,027	2,514
Minority Interest	141.81	110.7	50.37	8.82	6.06	3.02
Shareholders' Equity	3,078	3,011	3,013	3,228	3,033	2,517
Total Liabilities & Equity	3,811	3,524	3,414	3,725	3,808	3,692
Total Debt	81.5	123.8	57.41	14.13	20.01	-
Net Cash (Debt)	1,870	1,637	1,554	1,674	1,449	1,287
Net Cash Growth	31.60%	5.32%	-7.14%	15.51%	12.58%	15.86%
Net Cash Per Share	2.00	1.76	1.65	1.81	1.57	1.38
Filing Date Shares Outstanding	838.37	928.16	928.16	928.16	928.16	928.16
Total Common Shares Outstanding	838.37	928.16	928.16	928.16	928.16	928.16
Working Capital	1,784	1,755	1,814	2,085	1,957	1,556
Book Value Per Share	3.50	3.12	3.19	3.47	3.26	2.71
Tangible Book Value	2,785	2,802	2,867	3,121	2,942	2,426
Tangible Book Value Per Share	3.32	3.02	3.09	3.36	3.17	2.61
Buildings	-	375.5	371.29	437.94	436.85	434.78
Machinery	-	744.21	767.2	776.51	764.36	743.64
Construction In Progress	-	36.07	29.8	19.71	15.72	15.45

Source: S&P Capital IQ. Standard template. Financial Sources.